Loading organizations...
Loading organizations...
Advanced nucleic acid diagnostic technology and remote treatment products.
Fanzhi Medicine has raised $15.7M across 1 funding round.
Fanzhi Medicine has raised $15.7M in total across 1 funding round.
Fanzhi Medicine has raised $15.7M in total across 1 funding round.
Fanzhi Medicine's investors include GoldenSand Capital, Zhonghai Shengrong Capital.
Fanzhi Medicine has raised $15.7M across 1 funding round. Most recently, it raised $15.7M Series C in January 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 30, 2022 | $15.7M Series C | GoldenSand Capital, Zhonghai Shengrong Capital |